Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Zomedica Pharmaceuticals stock (ZOM)

Buy Zomedica Pharmaceuticals stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Zomedica Pharmaceuticals is a medical devices business based in the US. Zomedica Pharmaceuticals shares (ZOM) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $0.12 – the same closing value as a week prior. Zomedica Pharmaceuticals employs 144 staff and has a trailing 12-month revenue of around $26.1 million.

Our top picks for where to buy Zomedica Pharmaceuticals stock

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • Complimentary access to a financial planner

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

How to buy Zomedica Pharmaceuticals stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ZOM. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Zomedica Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a complimentary access to financial planners.
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
Robinhood
Finder Score: 4.5 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Zomedica Pharmaceuticals stock price (NYSE MKT: ZOM)

Use our graph to track the performance of ZOM stocks over time.

Zomedica Pharmaceuticals shares at a glance

Information last updated 2024-11-07.
Latest market close$0.12
52-week range$0.12 - $0.23
50-day moving average $0.13
200-day moving average $0.14
Wall St. target price$0.44
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.06

Is it a good time to buy Zomedica Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Zomedica Pharmaceuticals price performance over time

Historical closes compared with the close of $0.122 from 2024-11-11

1 week (2024-11-06) 0.122
1 month (2024-10-11) -6.15%
3 months (2024-08-13) -21.29%
6 months (2024-05-13) -12.86%
1 year (2023-11-13) -32.22%
2 years (2022-11-11) -49.15%
3 years (2021-11-12) 0.539
5 years (2019-11-13) 0.34

Zomedica Pharmaceuticals financials

Revenue TTM $26.1 million
Gross profit TTM $13.7 million
Return on assets TTM -9.29%
Return on equity TTM -23.92%
Profit margin -214.7%
Book value $0.21
Market Capitalization $121.5 million

TTM: trailing 12 months

Zomedica Pharmaceuticals share dividends

We're not expecting Zomedica Pharmaceuticals to pay a dividend over the next 12 months.

Zomedica Pharmaceuticals share price volatility

Over the last 12 months, Zomedica Pharmaceuticals's shares have ranged in value from as little as $0.1171 up to $0.2285. A popular way to gauge a stock's volatility is its "beta".

ZOM.US volatility(beta: 1.06)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Zomedica Pharmaceuticals's is 1.064. This would suggest that Zomedica Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Zomedica Pharmaceuticals overview

Zomedica Corp. , a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system.

Frequently asked questions

What percentage of Zomedica Pharmaceuticals is owned by insiders or institutions?
Currently 1.78% of Zomedica Pharmaceuticals shares are held by insiders and 8.331% by institutions.
How many people work for Zomedica Pharmaceuticals?
Latest data suggests 144 work at Zomedica Pharmaceuticals.
When does the fiscal year end for Zomedica Pharmaceuticals?
Zomedica Pharmaceuticals's fiscal year ends in December.
Where is Zomedica Pharmaceuticals based?
Zomedica Pharmaceuticals's address is: 100 Phoenix Drive, Ann Arbor, MI, United States, 48108
What is Zomedica Pharmaceuticals's ISIN number?
Zomedica Pharmaceuticals's international securities identification number is: CA98980M1095
What is Zomedica Pharmaceuticals's CUSIP number?
Zomedica Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 98979F107

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site